Joseph Sparano, MD
Enriched profileEzra M. Greenspan, M.D. Professor in Clinical Cancer Therapeutics and Chief of the Division of Hematology and Medical Oncology · Icahn School of Medicine at Mount Sinai
Joseph Sparano is Ezra M. Greenspan, M.D. Professor in Clinical Cancer Therapeutics and Chief of the Division of Hematology and Medical Oncology at Icahn School of Medicine at Mount Sinai. OpenAlex indexes 960 publications with 40,428 citations (h-index 93); ClinicalTrials.gov lists 15 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 25 Oct 2026
Joseph Sparano, MD, is Ezra M. Greenspan, M.D. Professor in Clinical Cancer Therapeutics and Chief of the Division of Hematology and Medical Oncology at Icahn School of Medicine at Mount Sinai. The public record shows 960 publications with 40,428 citations (h-index 93), centered on Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 16 companies, 6 NIH-funded awards (1999–2026).
- Most recent indexed publication: 2026 · Journal of the National Cancer Institute
- Top research focus: Breast Cancer Treatment Studies
- 15 registered trials on ClinicalTrials.gov
- Open Payments reporting from 16 companies
Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 51 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 334.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 25 Oct 2026
Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:
- Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol
Sponsor: Eastern Cooperative Oncology Group
- Leflunomide in Previously Treated Metastatic Triple Negative Cancers
Sponsor: Joseph Sparano
Industry payments
Updated 25 Oct 2026
16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Genentech, Inc.Program year20254 payments
- Genentech USA, Inc.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Aromatase Inhibitor100%Anastrozole79%Letrozole21%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 25 Oct 2026
6 NIH research awards on record, funded 1999–2026 per NIH RePORTER. The latest:
- Consortium for Advancing Management and Prevention of Cancer in People with HIV
Icahn School of Medicine at Mount Sinai
FY2026$21,522,826UM1CA121947 - Consortium for Advancing Management and Prevention of Cancer in People with HIV
Icahn School of Medicine at Mount Sinai
FY2026$611,696UM1CA121947 - Consortium for Advancing Management and Prevention of Cancer in People with HIV
Icahn School of Medicine at Mount Sinai
FY2026$276,428UM1CA121947
Congress activity
Updated 25 Oct 2026
218 congress contributions (2004–2026) across AACR, ASCO, ASH, ASTRO, ESMO, SABCS per OpenAlex. The most recent:
- Clinical utility of discordances between histomorphology and molecular biomarkers in precision oncology.
ASCO Annual Meeting
ASCO2026Co-author - Integrating BTK inhibition into R-da-EPOCH for HIV-related DLBCL.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 25 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Racial disparities in breast cancer: looking beyond the recurrence score.
Journal of the National Cancer Institute
Comment2026 - Development and Validation of a Multimodal-Multitask Deep Learning Approach for Estimating Late Distant Recurrence Risk in HR-Positive Early Breast Cancer.
Cancer research communications
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerArticle2,388 citations2018
- 03Prospective Validation of a 21-Gene Expression Assay in Breast CancerArticle1,389 citations2015
- 04
- 05
Network
Updated 25 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 25 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
scholars.mssm.edu/en/persons/joseph-sparano
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗
Mentions by others
where others cite or feature them- Other
ascopost.com/issues/june-10-2013/joseph-a-sparano-md-named-vice-chair-of-ecog-acrin-cancer-research-group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Other
montefiore.org/sparano-named-vice-chair-ecog-acrin-cancer-research-group
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →montefiore.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 25 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog-ecog-acrin.org ↗
- Deputy Director
Tisch Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗ - Member
Board of Managers, PreECOG Research Foundation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog.ecog-acrin.org ↗ - Member
Early Breast Cancer Trialists' Collaborative Group Steering Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog.ecog-acrin.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giantsofcancercare.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cm.healio.com ↗
Secondary affiliations
appointments beyond the home institution- Chair
AIDS Malignancy Consortium
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giantsofcancercare.com ↗ - Deputy Chair
ECOG-ACRIN Cancer Research Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →realpink.komen.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.podbean.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Gregg Stone, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Donna Mancini, MD
Icahn School of Medicine at Mount Sinai
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Eric Winer, MD
Yale School of Medicine
Norman Wolmark, MD
University of Pittsburgh
Hope Rugo, MD
City of Hope